Related Experiment Videos
Serum ferritin as a third marker in germ cell tumours
European Journal of Cancer & Clinical Oncology
|March 1, 1982
Summary
Serum ferritin shows promise as a marker for germ cell tumors. Persistently high levels indicate a poor prognosis, while decreasing levels suggest a positive treatment response, aiding in early detection of recurrence.
Area of Science:
- Oncology
- Clinical Chemistry
Background:
- Germ cell tumors (GCTs) require reliable monitoring markers.
- Standard markers like alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-HCG) are established for GCTs.
Purpose of the Study:
- To evaluate serum ferritin as an additional diagnostic and prognostic marker for GCTs.
- To correlate serum ferritin levels with treatment response and tumor recurrence.
Main Methods:
- Serial measurements of serum ferritin, AFP, and beta-HCG were performed in 12 GCT patients.
- Correlation of marker levels with clinical outcomes, including prognosis and recurrence.
Main Results:
- Elevated serum ferritin was detected in 10 of 12 patients during treatment.
- Persistently high serum ferritin, along with elevated AFP or beta-HCG, correlated with a poor prognosis.
- Decreasing serum ferritin levels indicated a favorable treatment response, while rising levels suggested recurrence or dissemination.
Conclusions:
- Serum ferritin may serve as a valuable marker for early detection of residual or recurrent GCTs.
- While not a specific tumor product, serum ferritin's dynamic changes are clinically significant in GCT management.